Gann-Mode

INO - Quick TA - Lots of bullish potential

Long
Gann-Mode Updated   
NASDAQ:INO   Inovio Pharmaceuticals, Inc.
Just a quick run-through of where INO may be headed in the next four or five months based on meaningful support and resistance, as well as the current volume being driven into it. I believe we are in a change of trend from its downtrend / consolidation from the initial years of trading back in 2000, and we have now conclusively broken several layers or time and price resistance, however, we really need to see the $16 level to be broken and exceeded to see where the potential upside will land. Though, things are looking good for short term, or long term holds, in my opinion. 👍
Cheers!
Comment:
We will certainly see a pullback to lower levels and make a lower high and attractive prices for more potential buyers, which will could be an excellent springboard for solidifying its transition into a continued uptrend.
Comment:

Fibonacci time clusters can signal potential trend change in vertical area, but if levels hold and close bullish beyond we can feel confiden in our long position.

Also, Green dashed lines are the symmetric projection clusters, meaning, we can buy on a pull back along these levels
Comment:
We really want to see diminishing sell volume on these pullbacks
Comment:
Also, the reason the fib-time clusters are important in the vertical zone between the 28th and 30th is that the convergence of the golden fann lines occurs in this same zone. We may see aggressive price action and volume on these dates, but as to WHERE the market wants to go, will be shown to us.
Comment:

Price coming down to lower levels, potential buy zone as said before between 11.50 and 12.50, if price respects those levels and doesnt go lower.
Comment:

As predicted the price broke 12.50 and went to retrace some of the lower pullback levels.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.